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Abstract. The importance of pharmaceutical co-crystals now has been recognized in order to improve the research 
and development in pharmaceutical industries. Low solubility of active pharmaceutical ingredient (API) has led to the 
growth of new pharmaceutical co-crystals formation as it enhances the physicochemical properties of the API.  In this 
works, preparation of new co-crystal formation between ibuprofen (IBP) with selected amino acid compounds were 
performed by using dry grinding and liquid assisted grinding (LAG) techniques. Ibuprofen (IBP) was selected as the 
API meanwhile glycine (GLY), L-alanine (ALA) and L-proline (PRO) were selected as co-crystal former (CCF) 
agents. The products of IBP-co-former from grinding experiments for the formation of co-crystals were characterized 
and verified using X-Ray Powder Diffraction (XRPD), Differential Scanning Calorimetry (DSC) and Fourier 
Transform Infra-Red Spectroscopy (FTIR). The finding reveals that the IBP-PRO co-crystals have successfully 
formed.  For IBP-PRO system, new crystalline peaks from XRPD were recorded at 2θ values of 4.374°, 5.436° and 
10.944° from dry grinding technique and 4.41°, 5.436° and 10.962° for liquid assisted grinding (LAG) technique. A 
new melting point of 257.49 °C was discovered for IBP-ALA indicates the possibility of co-crystals formation. On 
the other hand, the analysis for IBP-GLY shows that no co-crystals formed in the system. 
1 Introduction 
Since decades ago and until now there is no exact 
definition of co-crystal. Although many researchers came 
by different definition, co-crystal is commonly accepted 
as a crystal built out of two or more organic components 
and basically in their pure solid forms, under ambient 
conditions. The importance of pharmaceutical co-crystal 
now has been recognized in order to improve the research 
and development in pharmaceutical industries [1]. For a 
poorly soluble active pharmaceutical ingredient (API), 
the co-crystal approaches will improve the API’s 
solubility [2].   
Not limited to solubility, co-crystal also helps in 
improving other physicochemical properties such as 
stability, dissolution, and bioavailability of poorly water 
soluble drugs [3]. The properties of drug co-crystal can 
be modified by forming pharmaceutical co-crystals that 
usually has two compounds which are single API and a 
relevant co-crystal former (CCF). Pharmaceutical co-
crystal is a new level of pharmaceutical products as it 
offers a better option in optimizing the API 
physicochemical properties without changing the 
chemical composition of the API [4]. Any changes of 
properties due to the change of molecular composition of 
either the API or the CCF will affect the function of the 
drug. 
Grinding method was used as a screening process for 
the possibility of pharmaceutical co-crystal formation. In 
this paper, the mechanochemical method with grinding in 
absence of solvent is termed as “dry grinding”. 
Meanwhile the grinding experiment in the presence of 
solvent is termed as “liquid assisted grinding” (LAG). 
Grinding method is the most efficient method for co-
crystallization screening process compared to solution 
crystallization method (the most common method) that 
relies on evaporation and cooling of stoichiometric 
solution. This is due to the fact that only a little amount 
of solvent needs to be used so that the co-crystal 
formation can occur by reaction in a small liquid phase 
and/or through amorphous phase formation [5], [6]. 
Ibuprofen was used as an API while amino acid as CCF 
is believed to improve the solubility of the API by co-
crystallization process due to its zwitterionic state. 
However, it depends on the side chain of the amino acids 
which can be acidic or basic and strongly modifies the 
behaviour of the molecules [7]. 
One of important rule of thumb before preliminary 
work for co-crystal screening is carried out is to 
investigate the possibility of proton transfer involves 
during hydrogen bonding interaction, which might lead to 
salt formation instead of co-crystal. The investigation of 
this possibility can be predetermined by measuring the 
acid ionization constant, pKa. A common guideline is the 
‘rule of three’ which states that a salt formation can be 
expected when the difference of pKa between the acid and 
the conjugate acid of the base is greater than 3 units [8]. 
Empirical solution chemistry demonstrates that a pKa 
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difference of at least two units (between an acid and a 
base moiety) is required to form a salt that is stable in 
water [9]. Meanwhile, the pKa difference less than 3 units 
could result in co-crystal formation as the possibility of 
proton transfer is little. This rule is only a guideline that 
can be followed before preliminary work is conducted; 
however this rule is insufficient in verifying co-crystal 
formation. It is suggested that a crystal engineering 
approach must be based on complementary 
intermolecular interaction rather than just a single pKa
value [10].
2 Material and methods 
2.1 Materials 
Ibuprofen (IBP) (MW: 206.29 g/mol) was obtained from 
Shasun Pharmaceutical Limited, India (Batch No.: IB 
11070248)(SN Grade).The CCFs used were glycine, L-
alanine and L-proline. Glycine (GLY) (MW: 75.07 g/mol) 
was purchased from Sigma-Aldrich with purity of ≥98% 
while L-alanine (ALA) (MW: 89.09 g/mol) and L-proline 
(PRO) (MW: 115.13 g/mol) were purchased from Merck 
KGaA, Darmstadt, Germany with purity of of ≥98%. Fig. 
1 shows the molecular structure of API and CCFs used in 
this research that obtained from Cambridge Structure 
Database (CSD). 
 
(a) (b)
(c) (d)
Figure 1. Molecular structure of (a) ibuprofen; (b) L-proline; (c) 
L-alanine and (d) Glycine obtained from Cambridge Structure 
Database (CSD). 
2.2 Milling methodology 
In this work, two milling methods were used; i.e. (dry 
grinding method and LAG method). Ibuprofen (IBP) was 
co-milled with one of the selected CCF in oscillatory ball 
mill (Mixer Mill MM400, Retsch GmbH, Germany) 
using a 25 mL milling vial. Four stainless steel beads 
with size of 6 mm in diameter were used in the milling 
process. The IBP and the CCF were co-milled in 
stoichiometric ratio of 1:1 (0.01mol, 2.0658g:0.01mol, 
1.1541g), 1:2 (0.01mol, 2.0675g: 0.02mol, 2.3378g) and 
2:1 (0.02mol, 4.1233g:0.01mol, 1.1553g). The milling 
process was operated for 30 minutes at frequency of 30 
Hz. For LAG method, 2 drops of solvent (ethanol) were 
added into the mixture of IBP and the CCF before the 
milling process starts. 
3 Characterization methods 
3.1 X-Ray Powder Diffraction (XRPD) 
The co-crystal formation was determined using an XRPD, 
Rigaku D/Max-2000 (Rigaku, Japan) with Cu Kα 
radiation at a wavelength of 1.542 Å in continuous 
scanning mode. The scanning rate used was 0.1285° over 
2θ/min with the step size of 0.018°. The accelerating 
voltage of the XRPD used was   40 kV and the current 
was 30 mA.  The data were collected over 2θ range of 5° 
to 30°. 
3.2 Differential Scanning Calorimetry (DSC) 
Thermal analyses of the products were performed by 
using DSC (Mettler Toledo DSC 820) equipped with 
refrigeration cooling system. The products were weighed 
approximately to 6 mg which then crimped in a non-
hermetic aluminium pans (30 μl) and scanned at a heating 
rate of 10 °C/min in the range of 25 °C to 350 °C. This 
process was run under continuously purged dry nitrogen 
environment at a flow rate of 50 mL/min. 
3.3 Fourier Transform Infra-Red Spectroscopy 
(FTIR)  
A Thermo Nicolet 6700 FTIR Spectrometer was used to 
collect the IR spectra of the sample. The information was 
then used for the analysis of the possibility of proton 
transfers between the molecules. The scan was collected 
over the range of 515 to 4000 cm-1 for each product. The 
data was analysed using OMNIC software. 
4 Results and discussion 
4.1 Ionization constant rule for co-crystals 
formations 
The data was analysed using OMNIC software. The IBP 
and the amino acids used in this work have more than one 
pKa values, reflecting the ionization constants of acidic 
and basic moieties of the molecules. Table 1 shows the 
pKa values of both API and CCFs (i.e. ALA, GLY and 
PRO) used.  Based on the ‘rules of three’, the result of 
pKa values shown in Table 1 indicates that there are 
possibilities of co-crystals formed instead of salt for IBP-
PRO, IBP-GLY and IBP-ALA systems. This is due to the 
fact that the difference between the pKa value of the 
individual component (i.e. between acidic and basic 
moiety) is more than 2 units, whilst the difference in the 
pKa values between the two mixture components is less 
than 3 units. However the pKa2 of IBP-GLY shows the 
difference of more than 3 units, which might indicate the 
possibility of non co-crystal to form. 
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Table 1. The ionization constants for IBP the API and CCFs 
(ALA, PRO and GLY) 
Material pKa1*
pKa
2
*
pKa1  
(IBP- CCF) 
pKa2  
(IBP-CCF) 
Ibuprofen 
(IBP) 4.45 
12.6
2 - -
L-alanine 
(ALA) 2.35 9.69 2.10 2.93 
L-proline 
(PRO) 1.99 
10.9
6 2.46 1.66 
Glycine 
(GLY) 2.34 9.6 2.11 3.02 
*The values of pKa* values were obtained from Dawson, 1959 [11] 
4.2 Thermal analysis for preliminary 
characterization of co-crystal 
The screening of the IBP-CCF formation was carried out 
using two co-grinding methods (dry grinding and LAG). 
The feed to the co-grinding experiment was 1:1 ratio of 
IBP to CCF. The ground products from the experiment 
were analyzed using DSC. Table 2 shows the summary of 
the result obtained from the experiments. 
The result in Table 2 shows the summary of results 
concluded from the presence of new endotherm peaks 
detected in the DSC thermogram for the ground samples 
obtained from both IBP-ALA and IBP-PRO systems. 
However, for both samples, the presences of pure 
components were also detected, showing that the samples 
contain both possible co-crystals compounds and pure 
components of the starting materials.  The dry grinding 
method was applied to all IBP-CCF mixture system, 
while the LAG method was only carried out for the IBP-
PRO system. The tabulated result shows that the 
combination of IBP-PRO and IBP-ALA has high 
possibility of forming co-crystals due to the presence of 
new endotherm peaks that might corresponds to a new 
crystalline phase. Meanwhile, the endotherm profile of 
IBP-GLY shows the presence of two peaks which 
correspond to pure IBP and GLY components, and with 
no new peak detected, which could indicate that co-
crystal formation did not take place. 
Table 2. The ticked signs show the presence of melting peaks 
of components in the DSC thermogram, representing co-crystals 
and pure components. 
IBP-CC
System Methods
Cocrystals 
formation 
Pure 
Component 
IBP-GLY Dry Grinding X √
IBP-ALA Dry Grinding √ √
IBP-PRO Dry Grinding √ √
IBP-PRO Liquid-Assisted Grinding (LAG) √ √
 
L-proline appears to be an excellent candidate as a 
CCF as it shares the zwitterionic α-ammonium-
carboxylate synthon, which is common to all other 
natural amino acids favouring the main chain atom 
interaction [7]. Different with other amino acids, L-
proline is a constrained, rather rigid compound. In terms 
of formation of co-crystals, this rigidity can certainly be 
viewed as an entropic advantage over other, more flexible, 
conformer (entropic contribution) [7]. Assessment of L-
proline as a CCF was further investigated using different 
stoichiometric mol ratio, i.e. 1:2 (IBP:PRO) and 2:1 
(IBP:PRO) as both methods show a favourable result for 
the formation of IBP co-crystal. 
The characterization on the thermal behaviour of the 
samples was analysed by using DSC. Fig. 2(a-d) shows 
the thermograms patterns for the starting materials (pure 
API and CCFs) and the ground product of IBP-CCF 
using selected grinding method. 
Thermal behaviour analysis was carried out using the 
Differential Scanning Calorimetry by heating the samples 
between 25 °C to 400 °C at 10 °C/min heating rate. The 
DSC results show the IBP melts at 76.9 °C and 
evaporates at 285.38 °C. Meanwhile, GLY melts at 
253.26 °C, ALA melts at 286.49 °C. From Fig. 2(a), the 
heat analysis shows that the ground product consists of a 
mixture of IBP and GLY, and no co-crystal formation 
detected, as only the pure components peaks were 
observed. Meanwhile from Fig. 2(b), the endothermic 
peak of the ground product of IBP-ALA were present at 
the pure component of IBP peak. However, a new pek 
was observed at 257.49 °C, which could indicate a new 
phase. Nevertheless, the presence of two peaks from this 
results could indicate the presence of IBP and a new 
phase in the ground product IBP-ALA. 
The endothermic peaks of L-Proline shows some 
variable peaks which indicates the eutectic point and the 
melting point of the co-former at 118.39 °C and 
223.34 °C, respectively [12]. Fig. 2(c) and 2(d) show the 
results for IBP-PRO systems for both dry grinding and 
LAG method, using different stoichiometric ratios 
between the IBP and PRO. For dry grinding method, only 
one peaks was observed, i.e. at 73.76 °C (for all IBP:PRO 
ratios), which corresponds for IBP peak. Meanwhile, for 
LAG method, a new peak was observed at 107.89 °C for 
1:1 IBP:PRO ground product, which could indicate a new 
crystalline phase system. For 1:2 IBP:PRO system, one 
peak also was observed, at 104.16 °C and this could 
belong to the PRO peak or a new crystalline phase. 
However, for 2:1 IBP:PRO system, only IBP peak at 
73.76 °C was observed. 
The new phase detected from the thermal analysis 
could belong to the co-crystals, salt crystals or solvates. 
Thus, a FTIR analysis was carried out to ensure the type 
of crystals formed in the ground product. 
 
(a) 
 
  
 
DOI: 10.1051/03002 (2016), matecconf/2016MATEC Web of Conferences  66
ICCPE 2016
9030029
3
 
(b) 
 
(c) 
 
(d) 
Figure 2. Thermograms of the sample obtain after grinding of 
IBP and CCF. (a) IBP and GLY (Dry grinding); (b) IBP and 
ALA (Dry grinding); (c) IBP and L-Proline (Dry grinding); and 
(d) IBP and L-Proline (Liquid Assisted Grinding) 
4.3 Proton transfer analysis for salt formation 
The FTIR spectra of the sample IBP-PRO in the 
range >1500 cm-1 was analysed and the characteristic IR 
absorption band were compare with the pure IBP and 
pure PRO system. From Fig. 1 (a), the functional group 
of ibuprofen consists of aromatic ring and carboxylic acid 
whilst for L-proline contains an aliphatic ring, carboxyl 
group and amine group (Fig. 1(b)). The IR spectrum for  
1:1 IBP:PRO (LAG) (Fig. 3) shows peaks at 1634.42 cm-
1 for C=C stretching, 1711.30 cm-1 for –C=O in 
carboxylic acid, 1981.36 cm-1 for C-H vibration in R-
CH=CH2, 2553.95 cm-1 for –OH in carboxylic acid, 
2868.40 cm-1 and 2953.81 cm-1 for –CH3. This results 
show that there are no proton transfer activity for this 1:1 
IBP:PRO from LAG method. 
There are possibilities of proton transfer at both pure 
component (IBP and PRO) as both consist of –COOH 
bond and PRO has more advantage of proton transfer as it 
has the –NH+ and –COO- functional group. The –COO- of 
the PRO has the possibility for proton transfer activity by 
accepting one H+ to become –COOH and the –NH+ of 
PRO will have the possibility for removing one proton to 
become –NH. Thus from the result, it can be concluded 
that no solvates were observed, but however, the 
formation of salt (or proton transfer) for PRO cannot be 
concluded. 
 
Figure 3. IR Spectra for 1:1 IBP-PRO (LAG method) 
4.4 Crystalline structure phase change 
determination 
Fig. 4 (a) and (b) shows the comparison of XRPD 
patterns of the feed materials of IBP, L-proline and the 
ground products of IBP-PRO systems recovered from 
both grinding methods. For the product of IBP-PRO 
system, ratios between IBP and PRO were varies 
stoichiometrically, i.e. 1:1, 2:1 and 1:2 for IBP-PRO 
crystalline products from both grinding. 
The XRPD data show that new peaks were detected in 
all IBP:PRO ratios for both grinding methods. Table 3 
also shows that common peaks were recorded for the 
same stoichiometric ratio for method dry grinding and 
LAG methods. However, there are some new peaks 
recorded for LAG samples which were not observed in 
the product of the dry grinding. This is probably due to 
the presence of the ethanol solvent in the samples in 
which ethanol enhances the formation of co-crystal which 
results in increasing of intensity of new peaks. The same 
effects also were reported by Trask and co-workers [13] 
in their work in co-crystallization of caffeine and glutaric 
acid using dry grinding and LAG methods [14]. For dry 
grinding method, the XRPD pattern confirms the 
presence of the unique new crystalline peaks but the DSC 
results do not show new peak in its thermograms. 
By looking at Fig. 4(a) and 4(b) for IBP:PRO ratios of 
(2:1) and (1:2); peaks for pure components were also 
detected. For instance, for IBP:PRO ratios of (2:1), IBP 
peaks present together with the new phase peaks. Whilst 
for (1:2) ratios, PRO peaks were also detected. This is 
related to the act of the compound as limiting reactant in 
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the combination. As for IBP:PRO (2:1), the L-proline act 
as the limiting reactant due to no peak of L-proline 
discovered but there was peak of IBP discovered for the 
sample. The remaining of IBP that not consumed lead to 
the peak of IBP observed in XRPD for the sample 
IBP:PRO (2:1) ratios in Fig. 4(a) and 4(b). Meanwhile for 
IBP:PRO (1:2) system, the IBP acted as the limiting 
reactant as the same peak of PRO observed in the sample. 
This shows that the stoichiometric of 1:1 IBP:PRO 
system is the best option as both compound (IBP and 
PRO) were almost completely consumed as no same peak 
of both compound observed in the sample. 
 
 
(a) 
 
(b) 
Figure 4. XRPD patterns of IBP, PRO and IBP-PRO ground 
products obtained from (a) dry grinding method; and (b) Liquid 
Assisted Grinding method. New peaks were observed and 
shown by dotted lines on the graph and the 2 for the new peaks 
are listed in Table 3. 
Table 3. Peaks observed from the XRPD analysis, showing 
possibility of the presence of a new crystalline form. 
Co-crystal 
Formation 
Methods 
IBP-
PRO 
ratio
New peak Peak from raw materials 
Dry 
Grinding 1:1 
4.338°, 5.382°, 
10.854°,13.824° 
No peaks from 
raw materials 
observed 
2:1 
4.32°, 5.364°, 
10.818°, 13.30°, 
15.606° 
Peaks from 
ibuprofen 
observed 
1:2 4.338°, 5.382°, 10.872° , 15.57° 
Peaks from L-
proline 
observed 
Liquid 
Assisted 
Grinding 
(LAG) 
1:1 
4.392°, 5.436°, 
10.926°, 13.338°, 
15.300°, 16.182°, 
21.438° 
No peaks from 
raw materials 
observed 
2:1 
4.374°, 5.400°, 
10.872°, 13.266°, 
15.534°, 16.272° 
Peaks from 
ibuprofen 
observed 
1:2 
4.374°, 5.418°, 
10.908°, 13.248°, 
15.354°,  15.624° 
Peaks from L-
proline 
observed 
 
5 Conclusions 
The investigation on the possibility of co-crystal 
formation between ibuprofen (IBP) and three co-crystal 
formers (CCF) which are L-alanine (ALA), Glycine 
(GLY) and L-Proline (PRO) were carried out using co-
grinding method. There was no co-crystal formation 
observed on IBP-GLY system and a slight possibility of 
co-crystal formation for the IBP-ALA system. However, 
the IBP-PRO system shows high possibility of co-crystal 
formation and the best combination for IBP-PRO system 
is by using 1:1 stoichiometric ratio through liquid assisted 
grinding method in which ethanol was used as a solvent. 
The other stoichiometric ratio which are 1:2 and 2:1 
(IBP-PRO) are not suitable where excess of pure 
compound were found in the system. The IBP-PRO co-
crystal formed was found to obey the ‘rule of three’ rule 
in which the pKa difference is 2.56 units and the new 
phase was formed, which is suspected a co-crystal. 
However, salt formation cannot be confirmed.  
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